世界睡眠医学杂志2024,Vol.11Issue(7) :1490-1492.DOI:10.3969/j.issn.2095-7130.2024.07.019

度洛西汀联合盐酸曲唑酮治疗老年缺血性卒中后焦虑抑郁共病状态的疗效观察

Clinical Efficacy of Duloxetine Combined with Trazodone Hydrochloride in the Treatment of Anxiety and Depression Comorbidities after Ischemic Stroke in Elderly Patients

温月红 罗礼文
世界睡眠医学杂志2024,Vol.11Issue(7) :1490-1492.DOI:10.3969/j.issn.2095-7130.2024.07.019

度洛西汀联合盐酸曲唑酮治疗老年缺血性卒中后焦虑抑郁共病状态的疗效观察

Clinical Efficacy of Duloxetine Combined with Trazodone Hydrochloride in the Treatment of Anxiety and Depression Comorbidities after Ischemic Stroke in Elderly Patients

温月红 1罗礼文1
扫码查看

作者信息

  • 1. 福建省龙岩市第二医院神经内科,龙岩,364000
  • 折叠

摘要

目的:探究度洛西汀联合盐酸曲唑酮治疗老年缺血性卒中后焦虑抑郁共病状态的临床疗效.方法:选取2021年1月至2023年1月福建省龙岩市第二医院神经内科收治的缺血性卒中后焦虑抑郁共病状态的老年患者120例作为研究对象,按照随机数字表法分为对照组和观察组,每组60例.对照组患者给予盐酸曲唑酮片治疗,观察组在此基础上加用盐酸度洛西汀肠溶胶囊治疗,2组均连续治疗1个月.对比2组临床疗效、神经递质水平、焦虑及抑郁程度、睡眠质量、不良反应.结果:观察组总有效率95.00%,高于对照组81.67%(P<0.05);观察组治疗后去甲肾上腺素(NE)、5-羟色胺(5-HT)、多巴胺(DA)水平高于对照组,焦虑评分量表(SAS)、抑郁评分量表(SDS)、匹兹堡睡眠质量指数(PSQI)评分均低于对照组(均P<0.05);2组不良反应发生率比较差异无统计学意义(P>0.05).结论:度洛西汀联合盐酸曲唑酮治疗老年缺血性卒中焦虑抑郁共病状态的临床效果显著,能够有效改善患者的神经递质水平,减轻其焦虑抑郁程度,提高其睡眠质量.

Abstract

Objective:To explore the clinical efficacy of duloxetine combined with trazodone hydrochloride in the treatment of anxiety and depression comorbidities after ischemic stroke in elderly patients.Methods:A total of 120 elderly patients with anxie-ty and depression comorbidity after ischemic stroke admitted to Department of Neurology,the Second Hospital of Longyan City,Fu-jian Province from January 2021 to January 2023 were selected as the study objects,and were divided into control group and ob-servation group according to random number table method,with 60 cases in each group.The control group received treatment with trazodone hydrochloride tablets,while the observation group received additional treatment with duloxetine hydrochloride enteric coated capsules on this basis.Both groups received continuous treatment for 1 month.The clinical efficacy,neurotransmitter lev-els,anxiety and depression,sleep quality and adverse reactions were compared between the two groups.Results:The total effective rate of observation group was 95.00%,which was higher than that of control group(81.67%)(P<0.05).After treatment,norep-inephrine(NE),5-hydroxytryptamine(5-HT)and dopamine(DA)in observation group were higher than those in control group.Self-rating Anxiety Scale(SAS)scores,Self-rating Depression Scale(SDS)scores,Pittsburgh Sleep Quality Index(PSQI)scores were lower than control group(P<0.05).There was no statistically significant difference in the comparison of adverse re-actions between the two groups(P>0.05).Conclusion:The combination of duloxetine and trazodone hydrochloride in the treat-ment of anxiety and depression comorbidities in elderly patients with ischemic stroke has obvious clinical effects,which can effec-tively improve the level of neurotransmitters,reduce the degree of anxiety and depression,and improve the quality of sleep.

关键词

老年人/缺血性卒中/焦虑状态/抑郁状态/度洛西汀/盐酸曲唑酮/睡眠质量/神经递质

Key words

Aged/Ischemic stroke/Anxiety state/Depressive state/Duloxetine/Trazodone hydrochloride/Sleep quality/Neu-rotransmitter

引用本文复制引用

出版年

2024
世界睡眠医学杂志

世界睡眠医学杂志

ISSN:
参考文献量8
段落导航相关论文